The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.
暂无分享,去创建一个
F. Altice | E. Hoff | Martha J Bojko | Alyona Mazhnaya | Iuliia Makarenko | R. Marcus | Jaimie P. Meyer | Martha J. Bojko
[1] F. Altice,et al. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. , 2016, Drug and alcohol dependence.
[2] F. Altice,et al. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy , 2016, Journal of the International AIDS Society.
[3] F. Altice,et al. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment. , 2016, Journal of substance abuse treatment.
[4] K. Looker,et al. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] M. Schechter,et al. The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users , 2015, Journal of addiction medicine.
[6] G. Rutherford,et al. Misclassification of Men with Reported HIV Infection in Ukraine , 2015, AIDS and Behavior.
[7] S. Shoptaw,et al. Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions , 2015, Journal of acquired immune deficiency syndromes.
[8] L. Degenhardt,et al. Global Epidemiology of HIV Among Women and Girls Who Use or Inject Drugs: Current Knowledge and Limitations of Existing Data , 2015, Journal of acquired immune deficiency syndromes.
[9] K. Page,et al. HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment , 2015, Journal of acquired immune deficiency syndromes.
[10] C. Celum,et al. Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions , 2015, Journal of acquired immune deficiency syndromes.
[11] F. Altice,et al. “Bureaucracy & Beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine , 2015, Drugs.
[12] R. Booth,et al. Gender differences between predictors of HIV status among PWID in Ukraine. , 2014, Drug and alcohol dependence.
[13] F. Altice,et al. At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine. , 2013, Addiction.
[14] A. Adimora,et al. Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color. , 2013, AIDS patient care and STDs.
[15] R. D. Bruce,et al. Identifying Programmatic Gaps: Inequities in Harm Reduction Service Utilization among Male and Female Drug Users in Dar es Salaam, Tanzania , 2013, PloS one.
[16] Jacquelyn C. Campbell,et al. Forced Sexual Initiation, Sexual Intimate Partner Violence and HIV Risk in Women: A Global Review of the Literature , 2013, AIDS and Behavior.
[17] E. Puffer,et al. Changes in Religious Coping and Relapse to Drug Use Among Opioid-Dependent Patients Following Inpatient Detoxification , 2012, Journal of Religion and Health.
[18] T. Rhodes,et al. HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy , 2012, BMJ Open.
[19] P. Vickerman,et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[20] N. El-Bassel,et al. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer , 2012, Current opinion in HIV and AIDS.
[21] D. D. Des Jarlais,et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. , 2012, Drug and alcohol dependence.
[22] K. Laughon,et al. Intimate partner violence: a predictor of worse HIV outcomes and engagement in care. , 2012, AIDS patient care and STDs.
[23] P. Haber,et al. Unplanned pregnancy and contraceptive use in women attending drug treatment services , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.
[24] N. Volkow,et al. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. , 2011, Health affairs.
[25] F. Altice,et al. Substance abuse, violence, and HIV in women: a literature review of the syndemic. , 2011, Journal of women's health.
[26] R. D. Bruce,et al. HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study , 2011, Journal of acquired immune deficiency syndromes.
[27] M. Brandeau,et al. Effectiveness and Cost Effectiveness of Expanding Harm Reduction and Antiretroviral Therapy in a Mixed HIV Epidemic: A Modeling Analysis for Ukraine , 2011, PLoS medicine.
[28] N. El-Bassel,et al. Intimate Partner Violence and HIV Among Drug-Involved Women: Contexts Linking These Two Epidemics—Challenges and Implications for Prevention and Treatment , 2011, Substance use & misuse.
[29] J. Busza,et al. Street-based adolescents at high risk of HIV in Ukraine , 2010, Journal of Epidemiology & Community Health.
[30] S. Strathdee,et al. Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis , 2010, AIDS and Behavior.
[31] Jon Cohen. No opiate substitutes for the masses of IDUs. , 2010, Science.
[32] Z. Lazzarini,et al. Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. , 2009, The International journal on drug policy.
[33] E. Yano,et al. The Impact of Integrated HIV Care on Patient Health Outcomes , 2009, Medical care.
[34] L. Burruano,et al. HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. , 2009, Gender medicine.
[35] R. Coomber,et al. Injecting drug users: a stigmatised and stigmatising population. , 2009, The International journal on drug policy.
[36] Jacquelyn C. Campbell,et al. The intersection of intimate partner violence against women and HIV/AIDS: a review , 2008, International journal of injury control and safety promotion.
[37] R. Ali,et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. , 2008, Addiction.
[38] J. Attia,et al. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. , 2008, The journal of sexual medicine.
[39] C. Green,et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. , 2007, Drug and alcohol dependence.
[40] R. Booth,et al. Predictors of HIV sero-status among drug injectors at three Ukraine sites , 2006, AIDS.
[41] M. Newell,et al. Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. , 2006, European journal of public health.
[42] K. Walitzer,et al. Gender differences in alcohol and substance use relapse. , 2006, Clinical psychology review.
[43] M. Mundt,et al. Methadone Maintenance and Male Sexual Dysfunction , 2005, Journal of addictive diseases.
[44] G. Bobashev,et al. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. , 2004, American journal of public health.
[45] for the Hiv/aids Treatment Adherence, Health Outco,et al. Literature on integrated HIV care: a review , 2004, AIDS care.
[46] Patrick M Flynn,et al. Recovery from opioid addiction in DATOS. , 2003, Journal of substance abuse treatment.
[47] K. Theall,et al. HIV Risk Reduction Among African-American Women Who Inject Drugs: A Randomized Controlled Trial , 2003, AIDS and Behavior.
[48] M. Dugan,et al. Moderate or Severe Depression , 2002 .
[49] D. Gastfriend,et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. , 2000, The American journal of psychiatry.
[50] H. Skinner,et al. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. , 1989, British journal of addiction.
[51] R. Brislin. Back-Translation for Cross-Cultural Research , 1970 .
[52] Thomas Bremer. Religion in Ukraine: Historical Background and the Present Situation , 2016 .
[53] T. Flanigan,et al. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. , 2015, The International journal on drug policy.
[54] S. Filippovych. Impact of armed conflicts and warfare on opioid substitution treatment in Ukraine: responding to emergency needs. , 2015, The International journal on drug policy.
[55] C. Beyrer,et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. , 2014, The International journal on drug policy.
[56] C. G. Ng,et al. The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study. , 2014, The journal of sexual medicine.
[57] F. Altice,et al. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. , 2014, Drug and alcohol dependence.
[58] L. Johnston,et al. Correlates of HIV Risk Among Injecting Drug Users in Sixteen Ukrainian Cities , 2010, AIDS and Behavior.
[59] Randall T Brown,et al. Opioid Substitution with Methadone and Buprenorphine : Sexual Dysfunction as a Side Effect of Therapy , 2007 .
[60] Michele L. Ybarra,et al. Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R). , 2004 .
[61] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[62] Peter Piot,et al. Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .
[63] A. Strauss,et al. The Discovery of Grounded Theory , 1967 .